INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2023, Number 4

Cardiovasc Metab Sci 2023; 34 (4)

Cardiac myxoma

Ávalos-García, Yuritzi; Villalba-Hernández, Gerardo U; Flores-Méndez, Elio T; Morelos-Guzmán, Martha

ABSTRACT

Introduction: the most common primary cardiac tumors are myxomas, of which 75-85% are located in the left atrium and are prevalent in females. They may present with a triad of obstructive, embolism or constitutional symptoms. Case presentation: this study presents the case of a patient who, two years before being diagnosed with a cardiac myxoma, presented dyspnea that subsided with the use of a beta-blocker. After a surgical intervention, the symptoms of heart failure were exacerbated, and an echocardiogram showed a mass covering most of the left atrium and protruding through the mitral valve. Conclusion: the transthoracic echocardiogram is the first line of imaging for the diagnosis of myxoma. Magnetic resonance imaging (MRI) provides information on the location, size and characterization of the mass, in addition to helping the differential diagnosis with the presence of thrombus, essential data for the diagnosis approach and patient treatment.
  FULL TEXT PDF  

Keywords

cardiac myxoma cardiac magnetic resonance imaging echocardiogram




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Leptin: a description of its intriguing biology. A review. Part I
    2025, Vol.36, Núm. 1
  • Metformin in the management of non-alcoholic fatty liver disease: current...
    2025, Vol.36, Núm. 1
  • Statement from the Presidency of ANCAM and its Editorial Committee
    2025, Vol.36, Núm. 1
  • Inflammation indices in chronic stable coronary artery disease
    2025, Vol.36, Núm. 1
  • The MACARENHA connection: a holistic approach to understand and fight the...
    2025, Vol.36, Núm. 1
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3

Cardiovascular and Metabolic Science Vol. 34, Num. 4, Octubre-Diciembre 2023. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 https://www.cardiovascularandmetabolicscience.org.mx/ ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail addresses: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-061316491900-203. ISSN: 2683-2828 versión impresa y 2954-3835 versión electrónica. Ambos otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 04 de abril de 2024.

 

2025     |     https://www.cardiovascularandmetabolicscience.org.mx/